WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 31-July-2017 (data as of 19-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 28'5201 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 34'5271 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 46'348  46'398  46'522  46'698  46'857  40'904  39'306  37'797 
Births 407  415  424  435  446  403  404  585 
Surviving infants 406  414  423  433  445  401  401  577 
Pop. less than 5 years 2'065  2'169  2'239  2'324  2'406  1'891  2'108  3'181 
Pop. less than 15 years 6'849  6'917  6'932  6'948  6'951  6'034  7'859  9'795 
Female 15-49 years 10'445  10'583  10'770  10'968  11'162  10'612  9'810  9'006 

Number of reported cases

(Click for retrospective incidence data for Spain)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  37  115  154  131  1'204  152  21'650  145'322 
Mumps
ChartChart
  4'999  13'951  9'539  9'391 
Pertussis
ChartChart
  4'892  2'342  3'439  921  10'075 
Polio*
ChartChart
  17 
Rubella
ChartChart
  64  345 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  10  13  12  27  54  500 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Spain)
Vaccine year result method % card seen                                                
BCG         
DTP1         
DTP3          97  97  97  96  97  95  86 
DTP4          95  95  95 
IPV1         
HepB_BD         
HepB3          97  97  96  95  96  77 
Hib3          97  97  97  96  97  92 
JapEnc         
MCV1          97  96  96  95  97  94  99 
MCV2          95  95  93  91  90 
MenA         
PCV1         
PCV2         
PCV3          86 
Pol3          97  97  97  96  97  95  94 
Rota1         
RotaC         
RCV1          97  96  96  95 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Spain)
DTP1
ChartChart
  99  99  99  98  99  98  95 
DTP3
ChartChart
  97  97  97  96  97  95  86 
HepB3
ChartChart
  97  97  96  95  96  77 
HepB_BD
 
Hib3
ChartChart
  97  97  96  96  97  92 
MCV1
ChartChart
  97  96  96  95  97  94  99 
MCV2
ChartChart
  95  94  93  91  90 
PCV3
 
Pol3
ChartChart
  97  97  97  96  97  95  94 
RCV1
ChartChart
  97  96  96  95  97  94  99 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 19  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
CHOLERA Yes travelers
DTaPHibHepIPV 2, 6 months; Yes
DTaPHibIPV 4, 18 months; Yes
HepA_Adult Yes risk groups
HepA_Pediatric No 1 Region and 2 Cities (Ceuta and Melilla); Risk groups (all Regions)
HepB_Adult Yes risk groups
HepB_Pediatric birth; Yes
HPV 12 years (x2); Yes girls
Influenza_Adult >= 65 years; Yes and pregnant women, health care workers, adults with chronic diseases and other risk groups
Influenza_Pediatric Yes children with chronic diseases
IPV Yes travelers
MenACWY-135 conj Yes travelers
MenC_conj 4,12 months;12 years; Yes
MMR 12 months; 3-4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes risk groups
Pneumo_ps > 64 years; Yes risk groups
Td 14 years; Yes >=Y65; wound prophylaxis; adults without history vaccination
Tdap 6 years; Yes and pregnant women
Typhoid Yes travelers
Varicella 15 months; 3-4 years; Yes and susceptible adolescentand susceptible adolescents
YF Yes travelers

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  NA  NA  NA  NA 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number 19  19  19  19  19  19  19 
Nº districts with DTP3 coverage >=80% number 19  19  19  19  19  17  18 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  89  95 
Nº districts with measles (MCV1) coverage >=95% number 16  16  16  15  15  15  16 
% of districts with MCV1 coverage >=95% From 0 to 100% 84  84  84  79  79  79  84 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%           100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.